Early Detection of Pancreatic Cancer: Risk Factors and the Current State of Screening Modalities

Abstract: Pancreatic cancer (PC) is expected to become the second leading cause of cancer-related mortality in the United States within the next decade. Patients often present […]

Identification of People Infected With Hepatitis C Virus Who Have Never Been Diagnosed

G&H What is the current prevalence of hepatitis C virus infection in the United States? KK A recent population-based survey of the United States found […]

Screening for Nonalcoholic Fatty Liver Disease in the Primary Care Clinic

Abstract: Nonalcoholic fatty liver disease (NAFLD) is a spectrum of diseases ranging from simple hepatic steatosis to nonalcoholic steatohepatitis (NASH) to advanced fibrosis and cirrhosis […]

Economic Comparison of Serologic and Molecular Screening Strategies for Hepatitis C Virus

Abstract: Background: Hepatitis C virus (HCV) screening is traditionally performed using an enzyme-linked immunosorbent assay (ELISA), and HCV infection is confirmed by measuring the viral […]

Current Status and Future Directions for Screening Patients at High Risk for Pancreatic Cancer

Abstract: It is well known that pancreatic ductal adenocarcinoma has a high mortality rate. Despite progress in understanding the biology and genetic basis of this […]